Current stage -Stage I - Page 2 of 10 Posts on Medivizor
Navigation Menu

Current stage -Stage I Posts on Medivizor

Is conventional or hypofractionated radiation therapy better for the treatment of prostate cancer?

Posted by on Nov 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study compared two different types of radiation therapy after prostate surgery for prostate cancer, hypofractionated postprostatectomy radiation therapy (hypoPORT) and conventional postprostatectomy radiation therapy (coPORT). Results showed that hypoPORT may be effective in prostate cancer control and with similar side effects as...

Read More

Evaluating long-term outcomes of stereotactic body radiation therapy for low- and medium-risk prostate cancer

Posted by on Nov 13, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of stereotactic body radiation therapy (SBRT) as a treatment for prostate cancer. This study found that SBRT is a safe and effective option for low and medium risk prostate cancer. Some background Stereotactic body radiotherapy (SBRT) is a treatment option for...

Read More

Can men with low-risk prostate cancer on active surveillance be monitored only by PSA and MRI?

Posted by on Sep 7, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate if MRI scans (a test that takes detailed images of inside the body) could safely replace biopsies (samples taken from tissues for close examination) in active surveillance for prostate cancer. This study found that men with low-risk disease can be monitored using MRI and PSA levels with selective...

Read More

Are higher doses of radiation in less time better than conventional radiotherapy for prostate cancer?

Posted by on Sep 1, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate whether dose-escalated hypo-fractionated (higher doses in less time) radiation therapy would lead to better overall survival or less chance of cancer recurrence than the conventional method. They found that there is superior cancer control associated with dose-escalated hypo-fractionated radiation therapy for...

Read More

Comparing daily versus weekly imaging checks in radiation therapy for prostate cancer

Posted by on Aug 26, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the best timing of treatment verification imaging used in radiation therapy for patients with prostate cancer. This study found that patients undergoing daily imaging had less risk of their cancer returning and had reduced rectal side-effects. Some background One main treatment option for prostate cancer...

Read More

Comparison between low and high dose brachytherapy followed by radiation in prostate cancer

Posted by on Jul 3, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to compare urinary symptoms in men with localized prostate cancer treated with either low-dose or high-dose rate brachytherapy in combination with radiation therapy. The authors concluded the both low-dose and high-dose brachytherapy with IMRT was safe and well-tolerated by patients. However, it took longer to recover...

Read More

Comparing the side effects of treatment options for localized prostate cancer

Posted by on Jul 3, 2017 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the outcomes and side effects of radical prostatectomy, external beam radiation therapy, and active surveillance in men with localized prostate cancer. This study concluded that radical prostatectomy led to a greater decrease in sexual function and urinary continence compared to the other two treatment...

Read More

Searching for men to test focal therapy for ablation of prostate cancer

Posted by on Jun 6, 2017 in Prostate cancer | 0 comments

In a nutshell This study aims to test the effectiveness of focal ablation (laser therapy used to remove and kill cancer cells) of large prostate cancer sites using ultrasound and biopsy (tissue samples taken from the cancer site) one year after treatment. The main outcome to be measured will be the removal of cancer cells confirmed by a negative biopsy...

Read More

Focal therapy vs active surveillance in men with low-risk prostate cancer

Posted by on May 15, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the safety and efficacy of focal therapy compared to active surveillance in men with low-risk prostate cancer. The authors concluded that focal therapy was a safe and effective treatment option in men with low-risk prostate cancer. The also suggested that this treatment could be an option to avoid more...

Read More

The timing of first biopsy and its effect on prostate cancer reclassification

Posted by on Apr 3, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the influence of biopsy timing on prostate cancer reclassification during active surveillance.  The authors concluded that the timing of the first biopsy was not related to an increased risk of cancer reclassification, but prostate specific antigen (PSA) and body mass index (BMI – measured based...

Read More